GastroPlus in Model-informed Drug Development: PBPK Modelling, ACAT Modelling, and Regulatory Relevance
International Journal of Multidisciplinary and Medical Research · 14.08.2026 · 1 (Issue 2)
DOI: 10.67464/dbha8739 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Multidisciplinary and Medical Research, online erschienen am 14.08.2026. Verfasst von Mutiba Kamal.
Abstract (Originalsprache)
GastroPlus is a popular mid-21st century modeling software used in the drug developmentworld to simulate in vivo drug behaviours based on in vitro and physicochemical data. Itcombines the most important parameters of solubility, permeability, dissolution, particle size,pKa and gastrointestinal physiology to mimic drug absorption, distribution, metabolism, andexcretion (ADME). To make it easier to anticipate plasma concentration–time profiles invarious physiological and dosage settings, the platform integrates sophisticatedcompartmental modelling of the gastrointestinal tract and systemic pharmacokineticprocesses.Additionally, GastroPlus is a crucial tool in drug development for dose selection,bioavailability increase, formulation design optimisation, and reducing the need for extensiveanimal and human research. It turns out to be a useful technique for preclinical and clinicalassessments to determine how food, disease states, and population variability affect drugefficacy. Furthermore, it can be integrated with pharmacokinetic and pharmacodynamic(PK/PD) modelling, which helps in lead optimisation and regulatory submissions.GastroPlus is a complete in silico tool that can improve oral medication absorption andsystemic exposure prediction accuracy, reduce development costs, shorten time to market fornew therapies, and increase efficiency.
Zitieren
APA
Kamal, M. (2026). GastroPlus in Model-informed Drug Development: PBPK Modelling, ACAT Modelling, and Regulatory Relevance. International Journal of Multidisciplinary and Medical Research, 1(Issue 2). https://doi.org/10.67464/dbha8739
Vancouver
Kamal M. GastroPlus in Model-informed Drug Development: PBPK Modelling, ACAT Modelling, and Regulatory Relevance. International Journal of Multidisciplinary and Medical Research. 2026;1(Issue 2). doi:10.67464/dbha8739
BibTeX
@article{Kamal2026,
author = {Kamal, Mutiba},
title = {GastroPlus in Model-informed Drug Development: PBPK Modelling, ACAT Modelling, and Regulatory Relevance},
journal = {International Journal of Multidisciplinary and Medical Research},
year = {2026},
volume = {1},
number = {Issue 2},
doi = {10.67464/dbha8739}
}
EUVIMED